Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients

CONTEXT: The Indian government is dispensing newer direct-acting antiviral (DAA) drugs, which may have impact on hepatitis C virus (HCV) patients’ quality of life (QoL). AIMS: To evaluate different DAA regimens and impact on QoL in terms of quality-adjusted life year (QALY) in HCV patients and to me...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyas, Bhavya H., Darji, Nishita H., Rana, Devang A., Vyas, Kaushal Y., Malhotra, Supriya D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112329/
https://www.ncbi.nlm.nih.gov/pubmed/34012903
http://dx.doi.org/10.4103/picr.PICR_123_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112329/
https://www.ncbi.nlm.nih.gov/pubmed/34012903
http://dx.doi.org/10.4103/picr.PICR_123_19

Ejemplares similares